Syngenta AG is a provider of agricultural science and technology, in particular seeds and pesticides with its management headquarters in Basel, Switzerland. It is owned by ChemChina, a Chinese state-owned enterprise. Syngenta was founded in 2000 by the merger of the agrichemical businesses of Novartis and AstraZeneca, and acquired by China National Chemical Corporation (ChemChina) in 2017. Its business units are Syngenta Crop Protection, Syngenta Seeds, Adama, and Syngenta Group China. In 2020, the Syngenta Group was formed, bringing together Syngenta, Adama, and the agricultural business of Sinochem under a single entity. Syngenta's primary products include pesticides, selective herbicides, non-selective herbicides, fungicides, insecticides, as well as corn, soya, and biofuel. Syngenta brands include Actara (Thiamethoxam), Agrisure (corn with Viptera trait), Alto (Cyproconazole), Amistar (azoxystrobin), Avicta, Axial, Bicep II, Bravo, Callisto, Celest, Cruiser (TMX, Thiamethoxam), Dividend, Dual, Durivo, Elatus, Fusilade, Force, Golden Harvest, Gramoxone, Karate, Northrup-King (NK), Proclaim, Revus, Ridomil, Rogers, Score, Seguris, S&G, Tilt, Topik, Touchdown, Vertimec and Vibrance. The 2011 Dow Jones Sustainability Index, named Syngenta one of the best performing chemical companies worldwide. However, the company has been controversial, mainly due to its main business – selling toxic chemicals and the environmental impact of those chemicals – but also due to its investment in lobbying. In 2012, the company was nominated for the Public Eye Award, which denounces companies with questionable human rights practices. History Based in Basel, Switzerland, Syngenta was formed in 13 November 2000 by the merger of Novartis Agribusiness and Zeneca Agrochemicals. In 2004, Syngenta Seeds purchased Garst, the North American corn and soybean business of Advanta, as well as Golden Harvest Seeds. , Syngenta's main competitors were Monsanto Company, BASF, Dow AgroSciences, Bayer CropScience and DuPont Pioneer. In 2014, Monsanto sought to acquire Syngenta for a reported $40 billion, but Syngenta rejected the offer. Since April 2015, Monsanto and Syngenta had been working with their investment banks Morgan Stanley and Goldman Sachs respectively on a deal. The U.S. Treasury tried to stop the deal for tax inversion. Syngenta's Board of Directors rejected an even better offer by Monsanto during August 2015, and Monsanto withdrew from the negotiations on 26 August. In February 2016, ChemChina, a Chinese state-owned enterprise, offered to purchase Syngenta for $43 billion (480 Swiss francs per share), a deal which the company "unanimously recommended to shareholders". In April 2017, the Federal Trade Commission, the Committee on Foreign Investment in the United